• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Eitan taps InfuSystem for Sapphire pump maintenance deal

August 29, 2019 By Sean Whooley

InfuSystem - updated logoEitan Group said today that it inked a deal with InfuSystem (NYSE:INFU) for repair services on its fleet of Sapphire infusion pumps.

Madison Heights, Mich.-based InfuSystem plans to offer flat and al-la-carte options for Sapphire service and repair, citing a three-business-day turnaround goal on repairs.

“Our partnership with Eitan Group will create savings and improve satisfaction for hospitals and homecare pharmacies,” InfuSystem CEO Rich DiIorio said in prepared remarks. “As a trusted partner in our industry, InfuSystem services thousands of infusion pumps every month, prioritizing patient safety by delivering our best-in-class infusion pump service, repair, and expertise to healthcare providers in all 50 states and Canada. We are excited to collaborate with Eitan Group on this new service partnership.”

“InfuSystem has a well-established, nationwide repair and service offering, with long-standing expertise in the industry,” added Eitan Group North America CEO Roger Massengale. “With a focus on quality, InfuSystem will provide an efficient, compliant and cost-effective service and repair option to our customers. Eitan Group prides itself on being a service-oriented organization and we are always searching for ways to streamline service options for our customers. Our new partnership with InfuSystem will result in a lower total cost of ownership for our devices, which translates into savings for our customers.”

Filed Under: Drug-Device Combinations Tagged With: Eitan Group, infusystem

IN CASE YOU MISSED IT

  • FDA approves first targeted infusion therapy for HER2-low breast cancer
  • Abbott, WeightWatchers partner on diabetes care
  • Insulet up on Q2 sales beat, raised full-year guidance
  • Aptar acquires Orbital dry powder inhaler license
  • Tandem sinks on Q2 misses, slashed sales guidance

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS